IDIX 实验室看到大投资、丰厚的收益节拍和546美元的目标价格。 IDIX Laboratories sees big investments, strong earnings beat, and a $546 target price.

一家为兽医和水测试市场生产产品的公司,IDIX实验室,从摩根罗斯财富管理公司和法国巴黎银行等公司得到了大量投资,而Spire财富管理公司则减少了其持有量。 IDIX Laboratories, a company that produces products for veterinary and water testing markets, saw significant investment from firms like MorganRosel Wealth Management and BNP Paribas, while Spire Wealth Management reduced its holdings. 股票的评级为"中等买入",目标价为546.00美元, 报告了强的收益率, 每股收益为2.96美元, 相比预期的2.93美元. The stock, which has a "Moderate Buy" rating and a target price of $546.00, reported a strong earnings beat, with EPS of $2.96 compared to the expected $2.93. 该公司的市场资本总额为431.3亿美元。 The company's market capitalization is $43.13 billion.